The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2400018
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11007329.3
WO Publication Number:
EPO Publication Language:
German
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:
Dates
Filing date:
21/11/2003
Grant date:
04/05/2016
EP Publication Date:
28/12/2011
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
13/07/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
04/05/2016
EP B1 Publication Date:
04/05/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
13/07/2016
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/11/2023
Lapsed By Expiration Date:
21/11/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
07/05/2019
Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-Chome, 103-8411, Chuo-ku, Tokyo, Japan (JP)
Historical Applicant/holder
From:
04/05/2016
To:
07/05/2019
Name:
Ganymed Pharmaceuticals GmbH
Address:
An der Goldgrube 12, 55131 MAINZ, Germany (DE)
Domicile Holder
Name:
ir. H.A. Witmans c.s.
From:
13/07/2016
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)